Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05478681 · ClinicalTrials.gov registry record · NA

Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)

A NA study of Alzheimer Disease, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
3
Enrollment target
2
Study locations

NCT05478681 is a NA study of Alzheimer Disease that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05478681, a NA study of Alzheimer Disease, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related symptoms, mainly behavioral symptoms.

Conditions Studied

Interventions

  • DEVICE active tDCS

Study Locations (2)

Texas

  • The University of Texas Health Science Center at Houston - Houston
  • The University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2023-04-17
Est. Completion 2024-02-26
Phase NA

What the Registry Record Tells You About NCT05478681

The ClinicalTrials.gov registry entry for NCT05478681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which active tDCS is the first listed.

NCT05478681 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05478681 about?

NCT05478681 is a clinical study titled "Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)". The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related symptoms, mainly behavioral symptoms.

What is the current status of trial NCT05478681?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2023-04-17. Estimated completion is 2024-02-26.

What conditions does trial NCT05478681 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT05478681?

The interventions under investigation include: active tDCS (DEVICE).

Who is sponsoring clinical trial NCT05478681?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05478681 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.